Cue grants RSUs to CEO Shao-Lee Lin, CLO Sumita Ray and PAO Michael Meluzio
I'm LongbridgeAI, I can summarize articles.Cue Biopharma granted 1,064,492 restricted stock units (RSUs) on July 9, 2026, to executives and officers under its 2026 Stock Incentive Plan. CEO Shao-Lee Lin received 655,074 RSUs, CLO Sumita Ray received 109,178, PAO Michael Meluzio received 81,884, and each non-employee director received 21,800 RSUs.
Cue granted a total of 1,064,492 restricted stock units to employees and officers on July 9, 2026, including awards to President and CEO Shao-Lee Lin, Chief Legal and Compliance Officer Sumita Ray, and Principal Accounting Officer Michael Meluzio.
| Individual | Shao-Lee Lin | Sumita Ray | Michael Meluzio | Non-employee directors (each) |
| Role | President and Chief Executive Officer | Chief Legal and Compliance Officer and Corporate Secretary | Principal Accounting Officer | Director |
| Type of Change | Equity award granted | Equity award granted | Equity award granted | Equity award granted |
| Effective Date | July 9, 2026 | July 9, 2026 | July 9, 2026 | July 9, 2026 |
| Reason | To implement 2026 Stock Incentive Plan / long-term incentive framework | To implement 2026 Stock Incentive Plan / long-term incentive framework | To implement 2026 Stock Incentive Plan / long-term incentive framework | To implement 2026 Stock Incentive Plan / long-term incentive framework |
| Replacement Info | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
| Background Details | Received award of 655,074 RSUs | Received award of 109,178 RSUs | Received award of 81,884 RSUs | Each received 21,800 RSUs |
| Board/Committee Role Changes | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
Original SEC Filing: Cue Biopharma, Inc. [ CUE ] - 8-K - Jul. 10, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.